Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 26, 2024
With
the
increasing
number
of
people
with
HIV
(PWH)
and
use
antiretroviral
treatment
(ART)
for
PWH,
has
gradually
become
a
chronic
infectious
disease.
However,
some
infected
individuals
develop
issues
immunologic
non-responses
(INRs)
after
receiving
ART,
which
can
lead
to
secondary
infections
seriously
affect
life
expectancy
quality
PWH.
Disruption
gut
microbiota
is
an
important
factor
in
immune
activation
inflammation
HIV/AIDS,
thus
stabilizing
reduce
promoting
reconstitution
may
direction
HIV/AIDS.
This
paper,
based
on
extensive
literature
review,
summarizes
definition,
mechanisms,
solutions
INRs,
starting
from
perspective
microbiota.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 9, 2024
Antiretroviral
therapies
(ART)
have
reduced
human
immunodeficiency
virus
(HIV)
infection-associated
morbidity
and
mortality
improving
the
life
of
people
with
HIV
(PWH).
However,
ART
lead
to
residual
production,
which
in
conjunction
microbial
translocation
immune
dysfunction
contributes
chronic
inflammation
activation.
PWH
on
remain
at
an
increased
risk
for
cardiovascular
diseases
(CVDs)
including
myocardial
infarction
stroke;
part
is
explained
by
Lifestyle
factors
certain
are
associated
dyslipidemia
characterized
increase
low-density
lipoprotein
(LDL),
further
CVDs.
Lipid-lowering
agents
like
statins
emerging
as
modulators
decreasing
a
variety
conditions
HIV.
The
international
randomized
clinical
trial
REPRIEVE
has
shed
light
reduction
CVDs
statin
therapy
among
PWH.
Such
reports
indicate
more
than
expected
benefit
beyond
their
lipid-lowering
effects.
Bempedoic
acid,
first-in-class
non-statin
LDL-lowering
drug
modulatory
effects,
may
aid
combination
statins.
Herein,
we
critically
reviewed
studies
aimed
immune-modulating
roles
that
aging
Viruses,
Journal Year:
2021,
Volume and Issue:
13(7), P. 1266 - 1266
Published: June 29, 2021
In
stark
contrast
to
the
rapid
development
of
vaccines
against
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
an
effective
human
immunodeficiency
virus
(HIV)
vaccine
is
still
lacking.
Furthermore,
despite
virologic
suppression
and
CD4
T-cell
count
normalization
with
antiretroviral
therapy
(ART),
people
living
HIV
(PLWH)
exhibit
increased
morbidity
mortality
compared
general
population.
Such
differences
in
health
outcomes
are
related
higher
risk
behaviors,
but
also
HIV-related
immune
activation
viral
coinfections.
Among
these
coinfections,
cytomegalovirus
(CMV)
latent
infection
a
well-known
inducer
long-term
dysregulation.
Cytomegalovirus
contributes
persistent
PLWH
receiving
ART
by
directly
skewing
response
toward
itself,
increasing
through
modification
gut
microbiota
microbial
translocation.
addition,
induction
immunosenescence,
CMV
has
been
associated
decreased
infections
vaccines.
This
review
provides
comprehensive
overview
influence
on
system,
mechanisms
underlying
reduced
vaccines,
discuss
new
therapeutic
advances
targeting
that
could
be
used
improve
PLWH.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(9), P. 4830 - 4830
Published: April 29, 2024
HIV
infection
results
in
marked
alterations
the
gut
microbiota
(GM),
such
as
loss
of
microbial
diversity
and
different
taxonomic
metabolic
profiles.
Despite
antiretroviral
therapy
(ART)
partially
ablating
gastrointestinal
alterations,
profile
after
successful
new
ART
has
shown
wide
variations.
Our
objective
was
to
determine
GM
composition
functions
people
living
with
(PLWHIV)
under
comparison
seronegative
controls
(SC).
Fecal
samples
from
21
subjects
(treated
integrase
strand-transfer
inhibitors,
INSTIs)
18
SC
were
included.
We
employed
16S
rRNA
amplicon
sequencing,
coupled
PICRUSt2
fecal
short-chain
fatty
acid
(SCFA)
quantification
by
gas
chromatography.
The
INSTI
group
showed
a
decreased
α-diversity
(p
<
0.001)
compared
group,
at
expense
increased
amounts
Pseudomonadota
(Proteobacteria),
Segatella
copri,
Lactobacillus,
Gram-negative
bacteria.
Concurrently,
we
observed
an
enrichment
Megasphaera
Butyricicoccus,
both
SCFA-producing
bacteria,
significant
elevations
butyrate
this
0.001).
Interestingly,
dysbiosis
PLWHIV
characterized
proinflammatory
environment
orchestrated
elevated
levels
associated
bacterial
pathways,
well
evident
presence
butyrogenic
role
unique
should
be
evaluated,
use
butyrate-based
supplements
regimens
that
contain
succinate,
tenofovir
disoproxil
succinate.
This
mixed
is
described
for
first
time
Mexico.
Science Immunology,
Journal Year:
2024,
Volume and Issue:
9(100)
Published: Oct. 25, 2024
Gastrointestinal
(GI)
B
cells
and
plasma
(PCs)
are
critical
to
mucosal
homeostasis
the
host
response
HIV-1
infection.
Here,
high-resolution
mapping
of
human
PCs
sampled
from
colon
ileum
during
both
viremic
suppressed
infection
identified
a
reduction
in
germinal
center
(GC)
follicular
dendritic
(FDCs)
viremia.
Immunoglobulin
A-positive
(IgA
AIDS,
Journal Year:
2022,
Volume and Issue:
36(14), P. 1917 - 1925
Published: July 18, 2022
HIV-exposed
infected
(HEI)
and
uninfected
(HEU)
children
represent
the
two
possible
outcomes
of
maternal
HIV
infection.
Modifications
intestinal
microbiome
have
been
linked
to
clinical
vulnerability
in
both
settings,
yet
whether
HEI
HEU
differ
terms
gut
impairment
peripheral
inflammation/activation
is
unknown.We
performed
a
cross-sectional,
pilot
study
on
fecal
plasma
as
well
markers
damage,
microbial
translocation,
inflammation
immune
activation
HIV-infected
born
from
an
mother.Fecal
were
determined
by
means
16S
rDNA
amplification
with
subsequent
qPCR
quantification.
Plasma
quantified
via
ELISA.Forty-seven
33
consecutively
enrolled.
The
groups
displayed
differences
beta-diversity
relative
abundance,
similar
profiles
comparable
damage
translocation.
In
contrast,
monocyte
(sCD14)
systemic
(IL-6)
significantly
higher
than
HEU.In
setting
perinatal
infection,
enduring
do
not
appear
be
alterations
within
gut.
Given
that
are
independent
predictors
disease
progression,
future
studies
needed
understand
underlying
mechanisms
such
processes
elaborate
adjuvant
therapies
reduce
risk
individuals
Neurotherapeutics,
Journal Year:
2024,
Volume and Issue:
21(2), P. e00329 - e00329
Published: Feb. 22, 2024
Cognitive
impairment
remains
a
persistent
challenge
in
people
living
with
HIV
(PWLH)
despite
antiretroviral
therapy
(ART)
due
to
ART's
inability
eliminate
brain
HIV.
HIV-induced
cognitive
dysfunction
results
from
immune
dysregulation,
ongoing
neuroinflammation,
and
the
continuous
virus
presence,
collectively
contributing
deficits.
Therefore,
adjunctive
therapies
are
needed
reduce
cerebral
reservoirs,
mitigate
impede
progression.
Our
study
focused
on
Honokiol,
known
for
its
anti-inflammatory
neuroprotective
properties,
an
experimental
mouse
model
simulating
dysfunction.
Using
Honokiol
Hexafluoro
(HH),
synthetic
analogue,
we
comprehensively
evaluated
potential
ameliorate
pathology
HIV-associated
findings
showed
that
HH
treatment
effectively
reversed
dysfunction,
concurrently
suppressing
astrocyte
activation,
restoring
neuronal
dendritic
arborization,
reducing
microglial
activation.
Furthermore,
remodeled
metabolic
profile
of
HIV-infected
human
monocyte-derived
macrophages,
resulting
decreased
activation
promotion
quiescent
state
vitro.
Open Forum Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
11(5)
Published: March 28, 2024
Steatohepatitis
is
common
in
persons
living
with
HIV
and
may
be
associated
gut
microbial
translocation
(MT).
However,
few
studies
have
evaluated
the
gut-liver
axis
HIV.
In
Women's
Interagency
Study,
we
examined
associations
of
circulating
biomarkers
linked
to
MT
damage
using
FibroScan-aspartate
aminotransferase
(FAST)
score,
a
noninvasive
surrogate
for
steatohepatitis
advanced
fibrosis.
Among
883
women
354
without
HIV,
used
multivariable
regression
examine
serum
(kynurenine
tryptophan
ratio,
intestinal
fatty
acid-binding
protein,
soluble
CD14,
CD163)
log-transformed
FAST
score
after
adjusting
key
covariates.
We
path
analysis
mediation
models
determine
mediating
effect
each
biomarker
on
association
FAST.
infection
was
49%
higher
score.
levels
were
than
(P
<
.001
each).
mediated
13%
32%
Biomarkers
are
mediate
Our
findings
suggest
that
an
important
mechanism
by
which
increases
risk
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 20, 2024
Abstract
Gastrointestinal
(GI)
B
cells
and
plasma
(PCs)
are
critical
to
mucosal
homeostasis
the
host
response
HIV-1
infection.
Here,
high
resolution
mapping
of
human
PCs
sampled
from
colon
ileum
during
both
viremic
suppressed
infection
identified
a
reduction
in
germinal
center
(GC)
follicular
dendritic
(FDCs)
viremia.
IgA
+
major
cellular
output
intestinal
GCs
were
significantly
reduced
PC-associated
transcriptional
perturbations,
including
type
I
interferon
signaling,
persisted
antiretroviral
therapy
(ART)-treated
individuals,
suggesting
ongoing
disruption
immune
milieu
ART.
GI
humoral
perturbations
associated
with
changes
microbiome
composition
systemic
inflammation.
These
findings
highlight
key
defect
mucosa
due
One
Sentence
Summary
Intestinal
cell
linked
Aging,
Journal Year:
2021,
Volume and Issue:
13(19), P. 22772 - 22791
Published: Oct. 11, 2021
Anti-retroviral
therapy
(ART)
improves
life
expectancy
in
people
living
with
HIV
(PWH),
but
it
remains
unclear
how
chronic
infection
affects
normal
aging
of
the
immune
system.
Plasma
cell-free
protein
expression
and
phenotypes
were
assessed
blood
from
ART
treated
PWH
(19-77yrs,
n
=
106)
age-matched,
HIV-negative
controls
(HC,
103).
Using
univariate
spearman
correlation,
we
identified
277
491
age-associated
parameters
out
a
total
1,357
HC
PWH,
respectively.
exhibited
shared
distinct
profiles
compared
to
highlighting
effect
on
immunological
aging.
Our
analysis
resulted
an
8-parameter,
plasma-detectable
inflammatory
index
that
correlated
chronological
age
all
study
participants
was
higher
overall
PWH.
Additionally,
predictive
modeling
for
generated
25-parameter
signature,
IMAP-25,
70%
53%
accuracy
Applying
IMAP-25
signature
data
revealed
accelerated
by
5.6
yrs.
Overall,
our
results
demonstrate
signatures,
easily
monitored
human
samples,
can
be
used
as
indicator
one's
'immunological
age'
during
ART-treated
applied
other
disease
states
affect